In terms of well-known molecular markers, IDH mutation, 1p/19q codeletion, MGMT promotor methylation, wild-type TERT promoter, and ATRX mutation glioma samples correlated with lower infiltration of reactive astrocytes. This evidence concerns the gene MGMT and central nervous system cancer.